ArticleNPJ digital medicine2025
An AI-powered tongue image model for home-based monitoring of liver fibrosis.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Application of artificial intelligence in hepatology.Frontiers in digital health · 2026Review
- A portable non-contact tongue imaging system with automated analysis for community and home settings.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Liver fibrosis is a reversible precursor to cirrhosis, and early detection is key to halting disease progression. Tongue diagnosis provides a non-invasive and cost-effective insight into internal health; however, its subjectivity limits clinical reliability. We developed TongVMoe, a multi-task deep learning model trained on 2202 tongue images from 1601 patients, to detect liver fibrosis and simultaneously classify seven key tongue features. The model achieved an area under the curve (AUC) of 0.8061, outperforming State-of-the-Art methods such as DiffMIC-v2 (0.6929), HorNet (0.7018), InceptionNeXt (0.7012), LSNet (0.6971), and TransXNet (0.7062). TongVMoe also demonstrated robust recognition of tongue features, with AUCs of 0.9752 for cracks and 0.9232 for greasy coating. Among these features, petechiae emerged as a significant clinical indicator, showing a strong correlation with liver fibrosis (χ² = 19.516, P < 0.001). We further integrated the model into a WeChat mini-program and simulated remote screening, achieving an accuracy of 77.8% and a sensitivity of 86.2%. These findings suggest that the TongVMoe has the potential to serve as an interpretable and mobile-compatible tool for the early detection and monitoring of liver fibrosis, particularly in resource-limited areas. Trial registration: Chinese Clinical Trial Registry (ChiCTR2100053676, registered 27 November 2021).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.